| Previous Close | 52.75 |
|---|---|
| Volume | 15,372 |
| Day's Range | 52.54 - 52.79 |
| 52-Week Range | 37.60 - 54.26 |
| Year-to-Date Return | 1.55% |
|---|---|
| 1-Year Return | 37.66% |
| 3-Year Annualized Return | -0.51% |
| 5-Year Annualized Return | 3.28% |
| Expense Ratio | 0.48 |
|---|---|
| Net Assets | $ 557 mil |
| Alpha | 0.18 |
| R-Squared | 0.68 |
| Dividend (Yield) | $0.31 (1.99%) |
| Avg. Market Cap | $ 77,908 mil |
| Beta | 0.67 |
| Price/Earnings | 17.20 |
| Ex-Dividend Date | 12/21/2009 |
| Turnover | 8.00 |
| Standard Deviation | 4.72 |
| Price/Book | 4.94 |
| Management Company | BlackRock Fund Advisors |
| Administrator | BlackRock Fund Advisors |
| Company of Name | % of Total | # of Shares Held |
|---|---|---|
| 1. Johnson & Johnson | 8.46% | 721,468 |
| 2. Pfizer | 7.34% | 2,109,646 |
| 3. Novartis AG | 6.93% | 689,491 |
| 4. Roche Holding AG | 5.80% | 183,711 |
| 5. Merck & Co Inc | 5.69% | 798,589 |
| 6. GlaxoSmithKline PLC | 4.93% | 1,356,410 |
| 7. Abbott Laboratories | 3.99% | 404,206 |
| 8. Sanofi-Aventis SA | 3.89% | 279,851 |
| 9. AstraZeneca PLC | 3.30% | 378,917 |
| 10. Amgen Inc | 2.89% | 264,594 |
| % of Total Holdings | 53.22% |
| 12/11/2009 | Health-Care ETFs Get Tested (Barrons.com) |
| 12/1/2009 | Investments to ward off December's chill (MarketWatch.com) |
| 11/2/2009 | Market tricks and treats (MarketWatch.com) |
| 1/5/2009 | January's thaw could come from agriculture, midcaps, nat gas (MarketWatch.com) |
| 12/1/2008 | How to play offense and defense in December (MarketWatch.com) |
| 6/20/2008 | Health-Care Funds Are Ailing in 2008 (SM) |
| 12/12/2006 | Pfizer's Stumble Shows Why It's Better to Invest in the Sector (SM) |